| Type | Title | Date Released | |
|---|---|---|---|
10-Q | Form 10-Q | ||
8-K | Envoy Medical Reports Q3 2026 Results, Highlights Pivotal Trial Progress and FDA Regulatory Submissions for Acclaim Cochlear Implant | ||
8-K | Envoy Medical Announces 1-for-10 Reverse Stock Split | ||
8-K | Envoy Medical, Inc. Announces Voting Results from Special Meeting of Stockholders | ||
8-K | Envoy Medical Enters Dismissal Agreement to Resolve Litigation with Atlas Merchant Capital | ||
SCHEDULE 13G/A | Alta Partners LLC (Filed by) | ||
DEFA14A | Form DEFA14A | ||
DEF 14A | Form DEF 14A | ||
8-K | Envoy Medical, Inc. Appoints Robert Potashnick as Chief Accounting Officer and Vice President of Finance | ||
4 | Potashnick Robert (Reporting) | ||
PRE 14A | Form PRE 14A | ||
8-K | Envoy Medical Reports Q2 2026 Results and Progress on Acclaim® Cochlear Implant Regulatory and Clinical Milestones |
